When this FTSE 100 share drops below £16, I’d buy it every single time…

When this FTSE 100 share drops below £16, its dividend yield rises above 5%. Today, it’s slid below £15.50, making me a buyer once again.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Legendary US fund manager Peter Lynch once wisely remarked, “Never fall in love with a stock; always have an open mind”. But it’s fair to say that many investors do have favourite shares – and one of mine is a pillar of the FTSE 100.

My favourite FTSE 100 shares keep falling

In recent weeks, I have repeatedly written about FTSE 100 stocks that I consider ideally suited for value and income-seeking investors. The pattern seems to be: I write about a ‘bargain bin’ FTSE 100 stock, its price falls, and the share becomes even cheaper.

Of course, I’m not afflicted by any kind of stock-picking curse. The root cause is the fact that the wider FTSE 100 index has fallen roughly 470 points (7.25%) since its recent peak on 5 June. Also, my style of value and dividend-driven investing is very much out of favour these days.

Should you invest £1,000 in Tesco right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Tesco made the list?

See the 6 stocks

GlaxoSmithKline is a dividend dynamo

High on my list of favourite FTSE 100 shares is British pharmaceutical giant GlaxoSmithKline (LSE: GSK). I’ve owned GlaxoSmithKline shares for most of the past 30 years, going back to the early 1990s.

Perhaps, as Peter Lynch cautioned, I’ve fallen in love with this stock and have become biased and blind to GSK’s faults? I honestly don’t think this is the case, because this FTSE 100 share stacks up, no matter which way I analyse the underlying business.

As I write, and in today’s falling market, GSK shares trade at £15.48, down 25p (1.6%) since yesterday’s close. Therefore, GSK is worth around £1.2bn less today than it was yesterday (but on no new corporate information and for no particular reason).

My 5% Rule for GSK

Having watched GSK grow enormously since the 1980s, I’ve adopted what I call my ‘5% Rule’ for buying this FTSE 100 share.

For the past five years, GSK has paid a rock-steady dividend of 80p a share (plus a special dividend of 20p for 2015). At £16 a share, this equates to a dividend yield of 5%. Thus, when GSK shares drop below £16, their yield exceeds 5%. Conversely, the yield falls below 5% when GSK’s share price exceeds £16.

At today’s price of £15.48, GSK’s dividend yield has crept up to 5.17%, while its market value has declined to £78.9bn. Hence, according to my 5% Rule, GSK is now back in buying territory.

GSK is a FTSE 100 dividend beast

With almost 5bn shares in issue, paying out 80p a share in cash dividends costs this FTSE 100 firm around £4bn a year. This makes GSK one of the FTSE 100’s top-five dividend players. In fact, GSK’s dividend alone will account for up to 7% of total dividends paid by all UK-listed companies this year. This incredible figure demonstrates GSK’s sheer financial strength.

GSK’s next dividend of 19p will be paid on 8 October to investors who own this FTSE 100 share on 13 August.

GSK shares are cheap

Ignoring my ownership bias and long history with GSK, would I buy its shares today? Indeed I would, because the business is doing well and has a bright future. Yet GSK shares are down 6% in the past 12 months and are over £3 cheaper than their 52-week high of £18.57 hit on 24 January.

During the market’s March meltdown, GSK shares tumbled to £13.28 (on 16 March), boosting their dividend yield to above 6%. They were a bargain at the time and, based on my 5% Rule, my family bought even more.

Today, GSK shares trade on a price-to-earnings ratio of 11.8 and offer a dividend yield approaching 5.2%. Hence, I would buy and hold this FTSE 100 value share until the cows come home.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Older couple walking in park
Investing Articles

Could £300 a month invested in US and UK shares reach a million by retirement?

Could an investor retire with a million pounds just by dedicating £300 a month to US and UK shares? Mark…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

Is £800 enough to start an ISA?

Is it worth bothering with an ISA with less than £1,000 to spare? This writer believes it may be --…

Read more »

Investing Articles

3 reasons Tesla stock may be a long-term bargain

This writer is keen to buy Tesla stock at the right price. He doesn't think it's there yet -- but…

Read more »

Investing Articles

Nvidia stock is a lot cheaper than before – or is it?

Nvidia stock has been caught in the whirlwind of market volatility. This writer has been waiting to buy, so might…

Read more »

Top Stocks

3 FTSE stocks Fools are eyeing up for choppy markets

A selection of companies listed on the UK stock market on the watchlists of four Foolish investors.

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

A £10,000 investment in Rolls-Royce shares last week is now worth this…

Harvey Jones says Rolls-Royce shares couldn't escape the volatility of recent weeks, but wonders if the recent dip is a…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Prediction: in 2 years these S&P 500 stocks will be much higher than they are today

These two S&P 500 stocks have been beaten down in recent weeks. But Edward Sheldon expects them to move much…

Read more »

Investing Articles

10% yields! Why a volatile stock market is great news for passive income investors

The recent stock market volatility has given passive income investors the chance to earn double-digit returns. But they still need…

Read more »